Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One power score. Smarter investment decisions
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Sign Up
Markets
/
Stocks
/
nasdaq-mynz
/
Mainz Biomed NV
MYNZ
1.610
USD
-0.040
-2.42%
Close 09/19, 16:00(ET)
Quotes delayed by 15 min
USD
0.000
After-hours (ET)
3.73M
Market Cap
Loss
P/E TTM
Mainz Biomed NV
1.610
-0.040
-2.42%
Overview
Company
Financials
Analysis
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Overview
Company
Financials
Analysis
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024H2
FY2024H1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022H2
FY2022H1
Total revenue
--
373.22K
--
520.77K
--
214.76K
--
181.67K
--
248.94K
--
250.10K
--
290.07K
--
239.81K
Revenue
--
373.22K
--
520.77K
--
214.76K
--
181.67K
--
248.94K
--
250.10K
--
290.07K
--
239.81K
Cost of revenue
--
117.37K
--
201.74K
--
80.03K
--
94.48K
--
100.15K
--
111.16K
--
228.72K
--
119.00K
Operating expenses
--
8.98M
--
10.33M
--
6.81M
--
5.82M
--
8.18M
--
6.74M
--
14.15M
--
12.75M
R&D expenses
--
2.24M
--
2.96M
--
1.82M
--
1.72M
--
3.42M
--
2.47M
--
4.03M
--
886.36K
Depreciation, depletion, and amortization
--
554.24K
--
453.42K
--
204.47K
--
279.58K
--
304.80K
--
287.35K
--
317.43K
--
62.37K
Other operating expenses
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-69.11K
Operating profit
--
-8.61M
--
-9.81M
--
-6.59M
--
-5.64M
--
-7.93M
--
-6.49M
--
-13.86M
--
-12.51M
Net non-operating interest income (expenses)
Non-operating interest expense
--
411.77K
--
655.59K
--
565.59K
--
48.52K
--
49.83K
--
42.75K
--
173.41K
--
75.22K
Gains from sale of securities
--
-3.99K
--
-3.88K
--
-243.99K
--
46.58K
--
46.36K
--
39.41K
--
--
--
-40.70K
Special income (expenses)
--
-1.82M
--
-482.20K
--
709.68K
--
-29.25K
--
0.00
--
35.85K
--
--
--
--
Other non-operating income (expenses)
--
218.41K
--
-74.76K
--
1.51M
--
-627.93K
--
-322.18K
--
-105.87K
--
253.10K
--
23.82K
Income before tax
--
-10.63M
--
-11.02M
--
-5.18M
--
-6.30M
--
-8.25M
--
-6.56M
--
-13.78M
--
-12.60M
Income after tax
--
-10.63M
--
-11.02M
--
-5.18M
--
-6.30M
--
-8.25M
--
-6.56M
--
-13.78M
--
-12.60M
Net income from continuous operations
--
-10.63M
--
-11.02M
--
-5.18M
--
-6.30M
--
-8.25M
--
-6.56M
--
-13.78M
--
-12.60M
Net income attributable to controlling interests
--
-10.63M
--
-11.02M
--
-5.18M
--
-6.30M
--
-8.25M
--
-6.56M
--
-13.78M
--
-12.60M
Net income attributable to common shareholders
--
-10.63M
--
-11.02M
--
-5.18M
--
-6.30M
--
-8.25M
--
-6.56M
--
-13.78M
--
-12.60M
Basic earnings per share
--
-7.71
--
-19.73
--
-10.86
--
-15.78
--
-22.13
--
-17.87
--
-38.05
--
-36.47
Diluted earnings per share
--
-7.71
--
-19.73
--
-10.86
--
-15.78
--
-22.13
--
-17.87
--
-38.05
--
-36.47
Dividend per share
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
KeyAI
Please log in to use KeyAI
Log in
Sign Up